Dr. Andrea Schlegel is a certified abdominal transplant and HPB surgeon, currently working at the Careggi University Hospital in Florence, Italy. For more than 10 years, her research focuses on underlying mechanisms of ischemia/reperfusion injury and protective effects of novel machine perfusion technology. One of Andrea`s main interests is the development of new markers to predict viability during machine perfusion and to enable the safe use of high-risk donor livers. A new mitochondrial marker, released from complex I, was recently described to predict liver function and graft survival during hypothermic machine perfusion.